Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Anika Therapeutics, Inc.

Anika Therapeutics reports income of $0.07 per share

Total revenue for the fourth quarter of 2005 was $5,466,000 compared with $7,656,000 in the fourth quarter of 2004. The company reported net income of $823,000, or $0.07 per diluted share, for the fourth quarter of 2005, compared with $1,755,000, or $0.15 per diluted share, for the same period last year.

For the year ended December 31, 2005, total revenue increased 13% to $29,835,000 from $26,466,000 in 2004. Net income was $5,893,000, or $0.52 per diluted share, compared with $11,190,000, or $0.98 per diluted share, for 2004. The...

• View Other Issues of Law & Health Weekly
  
• View Other NewsRx Publications